CommentaryWill There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?
Under a Creative Commons license
open access
Cited by (0)
© 2019 International Society of Nephrology. Published by Elsevier Inc.